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ABSTRACT Hygienic measures imposed to control the spread of severe acute respi-
ratory syndrome coronavirus 2 (SARS-CoV-2) and contain COVID-19 have proven ef-
fective in controlling the pandemic. In this article, we argue that these measures
could impact the human microbiome in two different and disparate ways, acting as
a double-edged sword in human health. New lines of research have shown that the
diversity of human intestinal and oropharyngeal microbiomes can shape pulmonary
viral infection progression. Here, we suggest that the disruption in microbial sharing,
as it is associated with dysbiosis (loss of bacterial diversity associated with an imbal-
ance of the microbiota with deleterious consequences for the host), may worsen the
prognosis of COVID-19 disease. In addition, social detachment can also decrease the
rate of transmission of antibiotic-resistant bacteria. Therefore, it seems crucial to per-
form new studies combining the pandemic control of COVID-19 with the diversity of
the human microbiome.
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Among the main recommendations to fight the COVID-19 pandemic are to avoidinterpersonal contacts, to disinfect hands upon touching physical surfaces in
anthropogenic settings, and to follow strict respiratory etiquette rules to prevent the
spread of viral particles and aerosols contaminated with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Quarantine and confinement are also indicated
for the prevention of disease transmission in the case of individuals with suspected or
confirmed infection.
Social interconnections between people, however, also lead to the sharing of those
microorganisms that have been coevolving with humans and which are very important
for human health maintenance, contributing to the control of many diseases and
syndromes (1). The human microbiota engages in symbiotic or mutualistic relationships
within the human body. The collection of its genomes—the microbiome—is estimated
to account up to 99% of the unique genes in the human body (2) and provides genetic
information to perform many complementary functions that are lacking in the human
genome, such as helping to break down nutrients and molecules or to stimulate the
immune system (3). Changes in the balance of the gut microbiome (dysbiosis) are
associated with a greater susceptibility to diseases and opportunistic infections, due to
the decrease in the protective microbial load of symbiotic bacteria, which can lead to
dysregulation of the immune system and to autoimmune diseases (4). Such changes
were also found to be correlated with COVID-19 prognosis (5, 6). Yet there are no data
on the effect of human behavior during the COVID-19 pandemic on the gut microbiota.
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SOCIAL NETWORKING AND THE HUMAN MICROBIOME
The sharing of microorganisms between humans helps to build up the human
microbiome (Fig. 1). Microorganisms belonging to the oral, intestinal, and nasopharyn-
geal microbiomes can be transferred from person to person in a physical social
network. People living in the same home, i.e., sharing a household, are more likely to
harbor similar profiles of bacterial lineage diversity in their microbiomes, regardless of
their genetic relationships (7). Cohabitation has thus been reported as one of the main
factors facilitating the asymptomatic transmission typical of SARS-CoV-2 (8), accounting
for 45% of 793 new cases in Portugal in the period from 13 to 21 March 2020, according
to the governmental Health National Service (9). Other forms of social contact were also
relevant, namely, in companies (19%) and in nursing homes (11%). It seems reasonable
to consider that in the context of group or family confinement, each individual may
represent, in epidemiological terms, the entire group, as the individuals may share with
each other many microorganisms of the community.
Although some recent studies suggest that life in the womb is not completely
germfree (10–12), it has been argued that microorganisms do not colonize the baby
(13, 14) and that the human microbiome begins to be enriched following birth and
during the first 3 years of life. Vaginal birth and breastfeeding provide early contact
with maternal microorganisms and help in the establishment of both gut and airway
microbiomes, despite not being the main source of microbial diversity in adulthood
(15–17). Skin-to-skin or mucous contacts happening while kissing and hugging are thus
important sources of inoculation with human microorganisms from early life (18).
FIG 1 Schematic representation of the sharing of microorganisms of the human microbiome. On the left side,
individuals are connected and share their microorganisms (the colored symbols represent microbial diversity),
preserving the microbial diversity of their microbiomes but also the sharing of pathogens, such as COVID-19 and
antibiotic-resistant bacteria. The right side represents social distancing, which is an important tool in preventing
the spread of antibiotic-resistant bacteria and pathogens like SARS-CoV-2, but it can trigger dysbiosis leading
to the appearance of opportunistic infections and a worse prognosis for COVID-19. The scale at the bottom
represents the balance that should be reached between the preservation of the microbial diversity of the human
microbiome and infection transmission prevention (both situations having pros and cons).
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Also, contact with surfaces contaminated by humans can provide another important
indirect source of colonizing microorganisms from one human microbiome to another.
Babies and toddlers use their tongues to explore the household environment and, as
a result, can ingest a wide variety of new microorganisms, some of which will poten-
tially enrich their microbiota (19). The systematic disinfection of surfaces and hands can
disrupt this indirect source of human microbial inoculation.
SOCIAL DISTANCING AND THE HUMAN MICROBIOME
Interrupting the transmission of SARS-CoV-2 between individuals in a social network
through confinement and adherence to rules of hygiene and social distancing has been
important to contain COVID-19 spread, yet it also decreases the likelihood of sharing
other microorganisms of the human microbiota. This decreases the repertoire of
functional genes in our “other genome,” the gut microbiome (20), and could entail a
loss of functions, exposing humans to disease (Fig. 1).
Many factors have been driving to a loss of bacterial diversity from one generation
to the next in industrialized countries. Hygienic measures, vaccination, antibiotic use
(21), and cesarean sections, among other factors, are contributing to a loss of our
ancestral microbial heritage (15). Here, we postulate that the lack of contact between
humans resulting from the social distance measures recommended for COVID-19 might
also aggravate this situation and may increase the susceptibility of humans to disease.
THE CLOSED LOOP BETWEEN DYSBIOSIS AND COVID-19
Already in 1969, Johanson and colleagues observed differences in the oropharyn-
geal bacterial microbiota in individuals with severe pneumonia, but those changes
were not correlated with antibiotic administration or inhalation therapy, or with the
duration of hospitalization (22). If, on one hand, critical illnesses and intensive care
induce changes in the human microbiome, on the other, the changes in the lung and
intestine microbiome also modulate critical diseases, as demonstrated in animal models
and clinical trials (23). During lung infection, the induced shift in the microbiomes leads
to a positive-feedback loop of inflammation and dysbiosis (23).
The healthy microbiome is closely related to the functioning of the immune system,
and changes in the health status of the human host can have drastic effects on the
microbiome, and vice versa (24, 25). Dysbiosis in the gut has been associated with many
diseases, such as immune diseases like Crohn’s disease, ulcerative colitis, type 1
diabetes, celiac disease, allergy, and multiple sclerosis, metabolic diseases like obesity
or type 2 diabetes and colorectal cancer, and autism (26). This is of particular relevance
in elderly people that have a less diverse gut microbiota (5, 27).
It has been suggested that there is possible cross talk between the lung and the gut
microbiota that could influence the outcome of COVID-19 (5). For example, dysbiosis of
the gut microbiome can also increase the susceptibility to influenza virus infection in
the lungs (5, 28).
We are led to question whether the recommended social distancing measures to
prevent SARS-CoV-2 transmission could increase the number of other serious instabil-
ities. The breaking of the contagion pathways reduces the sharing of microorganisms
between people, thus favoring dysbiosis, which, in turn, may increase the poor prog-
nosis of the disease.
PERSON-TO-PERSON MICROBIAL TRANSMISSION AND ANTIBIOTIC RESISTANCE
It has been demonstrated that there is a positive correlation between the diversity
of antibiotic resistance genes and the diversity of bacterial virulence genes in human
metagenomes (29). Recently, using computer simulations, we have shown evidence
that in a social network, bacterial transmission from one person to another is the major
factor that explains this positive correlation between the diversity of antibiotic resis-
tance genes and the diversity of virulence genes. Therefore, simply because people
contaminate themselves in these social networks, we end up with the paradoxical and
unwanted situation in which humans with a higher diversity of virulence genes in their
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metagenomes are precisely those expected to have a high diversity of resistance genes
(30).
However, in some cases, antibiotic resistance entails a metabolic burden; hence,
after antibiotic treatment ends, there is a decline of resistance by gene loss and
competition with sensitive strains (31). This effect was highlighted in a metagenomic
study in which it was observed that that the diversity of genes encoding antibiotic
resistance in human intestinal microbiomes increases with age until reaching a limited
level (32).
In this context, we trust that there could be a potential beneficial effect of social
confinement in decreasing the spread of antibiotic-resistant microorganisms during
antimicrobial therapy. This hypothesis needs to be tested experimentally and, if con-
firmed, could support new recommendations for the use of antibiotics.
DISCUSSION
In this opinion article, we hypothesize that the social distancing imposed for
COVID-19 prevention might have an impact on the diversity of the human gut
microbiome and therefore on human health. We also argue that these measures could
have two opposite consequences for COVID-19: (i) the loss of biodiversity, if not
effectively restored, could be perennial and persist from one generation to the next,
potentially driving to disease and a poorer prognostic of COVID-19, in a perverse and
negative effect; (ii) social isolation and imposed hygiene rules can also lead to a
decrease in the transmission of microorganisms and their genes from one individual to
another, which might result in the dissociation of the correlation between the diversity
of bacterial antibiotic resistance genes and virulence genes (29, 30). This can be a
shorter-term positive effect that may not persist over time.
Social distancing implemented after the SARS-CoV-2 pandemic outbreak is therefore
a double-edged sword. It might have both negative and positive impacts on the
genomic dynamics of the human microbiome, and it is worth studying the implications
for public health.
The development of these lines of research could help to provide national health
systems with a comprehensive analysis of the confinement and social detachment
effect on individual and community health. It could also support decision-making and
measures to combat the pandemic, namely, in the definition of security protocols to
control COVID-19 without compromising human health. Nevertheless, it is important to
balance pandemic control with both the perverse effect of decreasing microbial
diversity and the beneficial effect of decreasing the spread of antibiotic-resistant
pathogenic bacteria (Fig. 1).
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